Semaglutide shortage sparks patient demands for alternatives But in Australia, the new drug generating the most interest is still in its infancy – and not yet listed on the PBS.
Viral weight loss drug linked to pancreatitis Semaglutide could be putting patients at greater risk of severe gastrointestinal complications when used for obesity management.
Diabetes policies should reflect GPs’ ‘central role’: RACGP The college has put forward 17 recommendations which it says ‘would greatly contribute’ to better diabetes care.
Does menstruation play a part in diabetes diagnosis? Researchers have suggested lowering HbA1c cut-offs for premenopausal women, but Australian GPs say more investigation is needed.
Do not initiate new patients on semaglutide: TGA The medication is again in short supply due to off-label prescribing for weight loss, despite only being approved for type 2 diabetes management.
Diabetes study successfully uses hookworm to combat disease Patients involved in the trial are choosing to live with worms in their gut, with research finding the larvae can improve insulin resistance.
Global diabetes cases to reach 1.3 billion by 2050: Study There are countries where as many as one in five people could be living with diabetes if current trends continue.
GlucaGen Hypokit in short supply until October Another diabetes medication is now facing supply issues, adding to worldwide shortages of semaglutide and dulaglutide.
Pharmacy green light for insulin swap due to shortage Pharmacists have been given permission to substitute a type of insulin pen due to ongoing supply issues that will likely last well into 2024.
GPs key for equitable access to glucose monitors: RACGP An ongoing NDSS review has sparked renewed calls to allow GPs to certify patients with diabetes for access to subsidised continuous glucose monitors.